Lista de obras -

(111)In-trastuzumab scintigraphy in HER2-positive metastatic breast cancer patients remains feasible during trastuzumab treatment.

artículo científico publicado en 2014

124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET).

artículo científico publicado en 2015

18-fluorodeoxyglucose positron emission tomography in the early diagnostic workup of differentiated thyroid cancer patients with a negative post-therapeutic iodine scan and detectable thyroglobulin

artículo científico publicado en 2013

18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement

artículo científico publicado en 2010

18F-Fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma

artículo científico publicado en 2008

6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications

artículo científico publicado en 2008

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine

artículo científico publicado en 2009

89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

artículo científico publicado en 2016

89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma

artículo científico publicado en 2017

89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.

artículo científico publicado en 2017

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

scientific article published on 26 November 2018

89Zr-bevacizumab PET imaging in primary breast cancer

artículo científico publicado en 2013

89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.

artículo científico publicado en 2014

89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake

artículo científico publicado en 2019

89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.

artículo científico publicado en 2014

<sup>18</sup>F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions

artículo científico publicado en 2021

Abstract OT3-2-01: IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic breast cancer (MBC)

Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma

artículo científico publicado en 2016

Antibody positron emission tomography imaging in anticancer drug development.

artículo científico

Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management

artículo científico publicado en 2020

Bone Marrow Function After (131)I Therapy in Patients With Differentiated Thyroid Carcinoma

artículo científico publicado en 2015

Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy

scientific article published on 01 August 2008

Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.

artículo científico publicado en 2005

Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.

artículo científico publicado en 2012

Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma

artículo científico publicado en 2020

Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.

artículo científico publicado en 2009

Comparative biodistribution analysis across four different Zr-monoclonal antibody tracers-The first step towards an imaging warehouse

artículo científico publicado en 2018

Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms

artículo científico publicado en 2020

Considerations on absence of 68Ga-DOTA-F(ab')2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions

artículo científico publicado en 2014

Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.

artículo científico publicado en 2012

Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma

artículo científico publicado en 2017

Drug concentration in lung tissue in multidrug-resistant tuberculosis.

artículo científico publicado en 2013

EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.

artículo científico publicado en 2015

Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.

artículo científico publicado en 2016

Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors

artículo científico publicado en 2014

Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues

artículo científico publicado en 2011

False positive spinal cord uptake on fluorodeoxyglucose positron-emission tomography following treatment of lymphoma

artículo científico publicado en 2012

False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors

artículo científico publicado en 2018

High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment

artículo científico publicado en 2019

Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas

artículo científico publicado en 2018

Image in endocrinology. Localization of an adrenocorticotropin-producing pheochromocytoma using 18F-dihydroxyphenylalanine positron emission tomography

artículo científico publicado en 2009

Images in cardiovascular medicine: myocardial metastases of carcinoid visualized by 18F-dihydroxy-phenyl-alanine positron emission tomography.

artículo científico publicado en 2008

Immunoscintigraphy as potential tool in the clinical evaluation of HER2/neu targeted therapy

artículo científico publicado en 2008

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

artículo científico publicado en 2008

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

artículo científico publicado en 2007

In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.

artículo científico publicado en 2014

In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer

artículo científico publicado en 2005

Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma

artículo científico publicado en 2015

Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma

artículo científico publicado en 2003

Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT

artículo científico publicado en 2019

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

scientific article published on 17 June 2019

Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: First clinical results ⬇️

artículo científico publicado el 6 de noviembre de 2010

Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma

artículo científico publicado en 2005

Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.

artículo científico publicado en 2012

Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma

scientific article published on 06 June 2019

Localization of parathyroid adenomas using (11)C-methionine pet after prior inconclusive imaging

artículo científico publicado en 2017

Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma

artículo científico publicado en 2020

Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma

artículo científico publicado en 2016

Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma

artículo científico publicado en 2018

Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma ⬇️

artículo científico publicado el 1 de junio de 2011

Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level.

artículo científico publicado en 2016

Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.

artículo científico publicado en 2008

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-FDG PET/CT analysis

artículo científico publicado en 2018

Medullary thyroid cancer, a tumour with many appearances

artículo científico publicado el 1 de enero de 2010

Molecular Imaging in Cancer Drug Development

artículo científico publicado en 2018

Molecular imaging biomarkers for immune checkpoint inhibitor therapy

artículo científico publicado en 2020

Molecular imaging for monitoring treatment response in breast cancer patients.

artículo científico

Monoclonal antibody therapy of kidney cancer

artículo científico publicado en 2003

Monoclonal antibody-based therapy for renal cell carcinoma

artículo científico publicado en 2003

Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets

artículo científico publicado en 2010

NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk

artículo científico publicado en 2017

Non-adherence to consensus guidelines on preoperative imaging in surgery for primary hyperparathyroidism

artículo científico publicado en 2020

Nuclear Medicine Imaging of Neuroendocrine Tumors

artículo científico

Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism

scientific article published on 31 July 2019

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re

artículo científico publicado en 2004

PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats

artículo científico publicado en 2004

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability

scientific article published on 30 March 2020

Pancreatic cyst development: insights from von Hippel-Lindau disease.

artículo científico publicado en 2013

Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study

artículo científico publicado en 2016

Pharmacokinetics and Tumor Targeting of 131I-Labeled F(ab9)2 Fragments of the Chimeric Monoclonal Antibody G250: Preclinical and Clinical Pilot Studies

scholarly article by Adrienne Brouwers et al published August 2004 in Cancer Biotherapy and Radiopharmaceuticals

Potential value of EUS in pancreatic surveillance of VHL patients

artículo científico publicado en 2016

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.

artículo científico publicado en 2009

Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study

artículo científico publicado en 2017

Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response

artículo científico publicado en 2005

Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study.

artículo científico publicado en 2015

Reversal of secondary protein-losing enteropathy after surgical revision of a jejunal Roux-en-Y loop in a patient after liver transplantation

artículo científico publicado en 2019

Tailored imaging of islet cell tumors of the pancreas amidst increasing options.

scientific article published on 25 June 2011

Targeted optical fluorescence imaging: a meta-narrative review and future perspectives

scientific article published in 2021

Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.

artículo científico publicado en 2003

The clinical applicability of low levels of thyroglobulin autoantibodies (TgAbs) as cut-off point for TgAb positivity

artículo científico publicado en 2018

The value of pre operative S-100B and SUV in clinically stage III melanoma patients undergoing therapeutic lymph node dissection ⬇️

artículo científico publicado el 31 de enero de 2011

Theranostics Using Antibodies and Antibody-Related Therapeutics.

artículo científico

Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.

artículo científico publicado en 2011

Total abdominal 18F-FDG uptake reflects intestinal adenoma burden in Apc mutant mice.

artículo científico publicado en 2011

Trastuzumab pharmacokinetics influenced by extent human epidermal growth factor receptor 2-positive tumor load.

artículo científico publicado en 2010

Use of S-100B to Evaluate Therapy Effects during Bevacizumab Induction Treatment in AJCC Stage III Melanoma ⬇️

artículo científico publicado el 23 de agosto de 2011

VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment.

artículo científico publicado en 2010

VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients.

artículo científico publicado en 2011

Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study.

artículo científico publicado en 2018

Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clinical dilemma in a patient with breast cancer.

artículo científico publicado en 2011

Lista de obras de

(111)In-trastuzumab scintigraphy in HER2-positive metastatic breast cancer patients remains feasible during trastuzumab treatment.

124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET).

18-fluorodeoxyglucose positron emission tomography in the early diagnostic workup of differentiated thyroid cancer patients with a negative post-therapeutic iodine scan and detectable thyroglobulin

18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement

18F-Fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma

6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine

89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma

89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

89Zr-bevacizumab PET imaging in primary breast cancer

89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.

89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake

89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.

<sup>18</sup>F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions

Abstract OT3-2-01: IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic breast cancer (MBC)

Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma

Antibody positron emission tomography imaging in anticancer drug development.

Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management

Bone Marrow Function After (131)I Therapy in Patients With Differentiated Thyroid Carcinoma

Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy

Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.

Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.

Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma

Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.

Comparative biodistribution analysis across four different Zr-monoclonal antibody tracers-The first step towards an imaging warehouse

Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms

Considerations on absence of 68Ga-DOTA-F(ab')2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions

Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.

Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma

Drug concentration in lung tissue in multidrug-resistant tuberculosis.

EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.

Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.

Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors

Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues

False positive spinal cord uptake on fluorodeoxyglucose positron-emission tomography following treatment of lymphoma

False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors

High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment

Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas

Image in endocrinology. Localization of an adrenocorticotropin-producing pheochromocytoma using 18F-dihydroxyphenylalanine positron emission tomography

Images in cardiovascular medicine: myocardial metastases of carcinoid visualized by 18F-dihydroxy-phenyl-alanine positron emission tomography.

Immunoscintigraphy as potential tool in the clinical evaluation of HER2/neu targeted therapy

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.

In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer

Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma

Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma

Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: First clinical results ⬇️

Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma

Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.

Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma

Localization of parathyroid adenomas using (11)C-methionine pet after prior inconclusive imaging

Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma

Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma

Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma

Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma ⬇️

Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level.

Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-FDG PET/CT analysis

Medullary thyroid cancer, a tumour with many appearances

Molecular Imaging in Cancer Drug Development

Molecular imaging biomarkers for immune checkpoint inhibitor therapy

Molecular imaging for monitoring treatment response in breast cancer patients.

Monoclonal antibody therapy of kidney cancer

Monoclonal antibody-based therapy for renal cell carcinoma

Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets

NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk

Non-adherence to consensus guidelines on preoperative imaging in surgery for primary hyperparathyroidism

Nuclear Medicine Imaging of Neuroendocrine Tumors

Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re

PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability

Pancreatic cyst development: insights from von Hippel-Lindau disease.

Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study